From	To	Reaction Type	Controller	Control Type	Cell Type	PMIDs	Genes	Drugs	Diseases	Summary
Tobacco Use Disorder	CYP1A2	Activation			null, hepatocyte	7895609	CYP1A2		Tobacco Use Disorder	Tobacco Use Disorder activates CYP1A2.
propranolol	n-desisopropylpropranolol	Biochemical Reaction	CYP1A2, CYP2D6	Gene	hepatocyte	18936551, 7895609, 2776392, 2776391		propranolol	Tobacco Use Disorder	Biochemical reaction from propranolol to n-desisopropylpropranolol. This interaction can be catalyzed by CYP1A2 or CYP2D6.
propranolol	propranolol glucuronide	Biochemical Reaction	UGT1A10, UGT1A9, UGT2B4, UGT2B7	Gene	hepatocyte	18936551, 16763014, 2776391		propranolol	Tobacco Use Disorder	Biochemical reaction from propranolol to propranolol glucuronide. This interaction can be catalyzed by UGT1A9, UGT1A10, UGT2B7 or UGT2B4.
propranolol	4-hydroxypropranolol	Biochemical Reaction	CYP1A2, CYP2D6	Gene	hepatocyte	18936551, 10945865, 7895609, 2776391		propranolol	Tobacco Use Disorder	Biochemical reaction from propranolol to 4-hydroxypropranolol. This interaction can be catalyzed by CYP1A2 or CYP2D6.
4-hydroxypropranolol	4-hydroxypropranolol glucuronide	Biochemical Reaction			hepatocyte	2776391			Tobacco Use Disorder	Biochemical reaction from 4-hydroxypropranolol to 4-hydroxypropranolol glucuronide.
4-hydroxypropranolol	4-hydroxypropranolol sulfate	Biochemical Reaction	SULT1A3	Gene	hepatocyte	15748705, 2776391			Tobacco Use Disorder	Biochemical reaction from 4-hydroxypropranolol to 4-hydroxypropranolol sulfate. This interaction is catalyzed by SULT1A3.
n-desisopropylpropranolol	naphthoxylactic acid	Biochemical Reaction	ALDH2, MAOA	Gene	hepatocyte	12269395, 9399616			Tobacco Use Disorder	Biochemical reaction from n-desisopropylpropranolol to naphthoxylactic acid. This interaction can be catalyzed by MAOA or ALDH2.
